Short echo spectroscopic imaging of the human brain at 7T using transceiver arrays
Recent advances in magnet technology have enabled the construction of ultrahigh‐field magnets (7T and higher) that can accommodate the human head and body. Despite the intrinsic advantages of performing spectroscopic imaging at 7T, increased signal‐to‐noise ratio (SNR), and spectral resolution, few...
Saved in:
| Published in | Magnetic resonance in medicine Vol. 62; no. 1; pp. 17 - 25 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.07.2009
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0740-3194 1522-2594 1522-2594 |
| DOI | 10.1002/mrm.21970 |
Cover
| Summary: | Recent advances in magnet technology have enabled the construction of ultrahigh‐field magnets (7T and higher) that can accommodate the human head and body. Despite the intrinsic advantages of performing spectroscopic imaging at 7T, increased signal‐to‐noise ratio (SNR), and spectral resolution, few studies have been reported to date. This limitation is largely due to increased power deposition and B1 inhomogeneity. To overcome these limitations, we used an 8‐channel transceiver array with a short TE (15 ms) spectroscopic imaging sequence. Utilizing phase and amplitude mapping and optimization schemes, the 8‐element transceiver array provided both improved efficiency (17% less power for equivalent peak B1) and homogeneity (SD(B1) = ±10% versus ±22%) in comparison to a transverse electromagnetic (TEM) volume coil. To minimize the echo time to measure J‐modulating compounds such as glutamate, we developed a short TE sequence utilizing a single‐slice selective excitation pulse followed by a broadband semiselective refocusing pulse. Extracerebral lipid resonances were suppressed with an inversion recovery pulse and delay. The short TE sequence enabled visualization of a variety of resonances, including glutamate, in both a control subject and a patient with a Grade II oligodendroglioma. Magn Reson Med, 2009. © 2009 Wiley‐Liss, Inc. |
|---|---|
| Bibliography: | ark:/67375/WNG-9TNPHM93-R ArticleID:MRM21970 istex:50D333DAF2227FA28C6782B0683B96E9B222EDB9 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 ObjectType-Feature-1 |
| ISSN: | 0740-3194 1522-2594 1522-2594 |
| DOI: | 10.1002/mrm.21970 |